Kristine Macartney
Profile
Professor Kristine Macartney was a researcher with the APPRISE Centre of Research Excellence that ended in December 2022.
Professor Macartney is a paediatrician specialising in infectious diseases and vaccinology. She is the Director of the Australian National Centre for Immunisation Research and Surveillance (NCIRS), a staff specialist in Infectious Diseases at The Children’s Hospital at Westmead and a conjoint academic in the Discipline of Paediatrics and Child Health at the University of Sydney. Kristine leads two national surveillance networks – the Paediatric Active Enhanced Disease Surveillance (PAEDS) network (across seven hospitals and approximately eight conditions) and the AusVaxSafety active vaccine safety surveillance network. She is the senior editor of the Australian Immunisation Handbook (9th Edition, 2008 and 10th Edition, 2013) and has authored more than 110 peer-reviewed publications.
Professor Macartney is interested in all aspects of vaccinology and vaccine preventable disease control, especially viral diseases, vaccine policy-making and vaccine safety. She has had roles on numerous key peak advisory committees, including the Australian Technical Advisory Group on Immunisation (ATAGI), and the Advisory Committee on Vaccines (ACV) of the TGA. In the last five years, she has been an investigator on NHMRC grants on vaccines and infectious diseases totalling $9.8 million in funding.
Related Projects
- Community perspectives on distributing an initially limited supply of vaccines in the event of an influenza pandemic
- Human parechovirus 3 (HPeV3) recombinant strain diversity and severe disease association in Australian outbreaks
- National and targeted sero-surveys of population immunity to SARS-COV2 to inform clinical and public health responses
- Sampling, shipping and serology: a proof of concept study of influenza immunity
Related Publications
- Real world impact of 13vPCV in preventing invasive pneumococcal pneumonia in Australian children: A national study
- Serological testing of blood donors to characterise the impact of COVID-19 in Melbourne, Australia, 2020
- Relative effectiveness of COVID-19 vaccination with 3 compared to 2 doses against SARS-CoV-2 B.1.1.529 (Omicron) among an Australian population with low prior rates of SARS-CoV-2 infection [preprint]
- Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2-specific antibodies in Australia after the first epidemic wave in 2020: A national survey
- Prospective characterisation of SARS-CoV-2 infections among children presenting to tertiary paediatric hospitals across Australia in 2020: a national cohort study
- ATAGI 2021 annual statement on immunisation Last updated: 19 September 2021
- The impact of the COVID‐19 pandemic on routine vaccinations in Victoria
- Constructing an ethical framework for priority allocation of pandemic vaccines
- Where has all the influenza gone? The impact of COVID-19 on the circulation of influenza and other respiratory viruses, Australia, March to September 2020
- Seroprevalence of SARS-CoV-2-specific antibodies in Sydney, Australia following the first epidemic wave in 2020
- COVID-19 public health measures and respiratory syncytial virus
- Transmission of SARS-CoV-2 in Australian educational settings: a prospective cohort study
- Causes and clinical features of childhood encephalitis: A multicenter, prospective cohort study
- Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander People, Australia, 2011–2015
- Evolutionary analysis of human parechovirus type 3 and clinical outcomes of infection during the 2017-18 Australian epidemic
- Influenza epidemiology, vaccine coverage and vaccine effectiveness in children admitted to sentinel Australian hospitals in 2017: Results from the PAEDS-FluCAN Collaboration
- Parechovirus: an important emerging infection in young infants